SCHEMBL18565856

SCHEMBL18565856

CC1(C)c2ccccc2-c2ccc(-c3ccc4c5ccccc5n(-c5ccc(-c6nc(-c7ccc(-n8c9ccccc9c9ccc(-c%10ccc%11c(c%10)C(C)(C)c%10ccccc%10-%11)cc98)cc7)nc(-c7ccc(-n8c9ccccc9c9ccc(-c%10ccc%11c(c%10)C(C)(C)c%10ccccc%10-%11)cc98)cc7)n6)cc5)c4c3)cc21

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HDAC4 P56524 1/20 0.32
▸ PDK2 Q15119 5/20 0.31
▸ RXRA P19793 1/20 0.31
▸ RXRB P28702 1/20 0.31
▸ F2 P00734 1/20 0.31
▸ F10 P00742 1/20 0.31
▸ PRSS1 P07477 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.30
▸ RXFP1 Q9HBX9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19061651 0.97 KDM4E (0.35) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL19061316 0.97 KDM4E (0.35) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL18385678 0.97 KDM4E (0.34) KDM4EATML3MBTL1HDAC4RXRA
SCHEMBL19061509 0.96 KDM4E (0.35) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL18565852 0.96 KDM4E (0.33) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL19061520 0.95 KDM4E (0.34) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL18385184 0.95 KDM4E (0.35) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL18565885 0.95 KDM4E (0.33) KDM4EATML3MBTL1HDAC4
SCHEMBL19061541 0.95 KDM4E (0.35) KDM4EATML3MBTL1HDAC4PDK2
SCHEMBL18565857 0.94 KDM4E (0.33) KDM4EATML3MBTL1PDK2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 KDM4E 225/4885ATM 3092/4885L3MBTL1 1263/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 KDM4E 225/4885ATM 3092/4885L3MBTL1 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback